GlassScriptPhysician profile
Adam Kibel
NPI 1285650580
$92,029.19
in general payments reported to CMS, 2019-2025
21 companies · $286 in 2025
The $286 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $25K · 2021: $15K · 2022: $9,046 · 2023: $5,159 · 2024: $4,512 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,843 · Honoraria: $1,800 · Food and Beverage: $1,314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,842.50 |
| Honoraria | $1,800.00 |
| Food and Beverage | $1,313.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $17,947.14 | 2019-2024 | |
| Janssen Research & Development, LLC | $15,524.37 | 2019-2023 | Erleada |
| Janssen Scientific Affairs, LLC | $12,431.06 | 2019-2023 | Erleada, Akeega |
| E.R. Squibb & Sons, L.L.C. | $12,375.00 | 2020-2024 | |
| Insightec,INC | $7,880.76 | 2019-2020 | |
| Ge Healthcare | $4,400.00 | 2020 | |
| Myovant Sciences INC. | $3,950.00 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $3,444.00 | 2020-2021 | |
| Pfizer INC. | $2,091.83 | 2023 | |
| Blue Earth Diagnostics | $2,000.00 | 2022 | |
| Exelixis INC. | $1,980.00 | 2021 | |
| Tolmar, INC. | $1,800.00 | 2024 | |
| Insightec,LTD | $1,577.28 | 2019 | |
| Progenics Pharmaceuticals, INC. | $1,350.00 | 2020 | |
| Janssen Global Services, LLC | $1,240.00 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Uk Limited | $1,074.00 | 2020 | |
| Edap Technomed INC | $513.00 | 2024 | |
| Janssen Biotech, INC. | $289.30 | 2024-2025 | Erleada |
| Astellas Pharma US INC | $78.58 | 2021 | |
| Urogen Pharma, INC. | $51.03 | 2025 | |
| Medtronic, INC. | $31.84 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Kibel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.